4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000172
EVP, Chf Clinical Develop Ofcr sold 9,549 shares at $42.80 ($408,701)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneider Eugene EVP, Chf Clinical Develop Ofcr | 2025-08-04 | Sale 10b5-1 | −9,549 | $42.80 | $408,701 | 51,507 | D: show line 1 in the form |
| Open-market sales · 9,549 sh · avg $42.80 · $408,701 | |||||||
Loading xslF345X05/edgardoc.xml…